The hypothetical risk of illness is enough of a motivating factor for people to take action, according to a study published in the Journal of Health and Social Behavior.
The hypothetical risk of illness is enough of a motivating factor for people to take action, according to a study published in the Journal of Health and Social Behavior.
Co-authors Rene Almeling, assistant professor of sociology at Yale University, and Shana Kushner Gadarian, assistant professor of political science at Syracuse University, asked participants to imagine they faced a genetic risk for a disease and assessed who wanted to take what kind of actions in response.
“Medical sociologists contend that we are living in an era of surveillance medicine, in which the emphasis on risk blurs the lines between health and disease,” the authors contended.
Participants were randomly assigned a level of risk and a disease: heart disease, colon cancer, or Alzheimer’s disease. The authors found that as the level of risk increased from 20% to 80%, people were more likely to want to take action of all kinds, including seeking information about the disease, taking medications or undergoing surgery to manage the risk, and organizing finances.
“Social scientists have argued that we are now treating risk as if it were a disease, and these results provide strong evidence for that claim,” Dr Almeling said in a statement.
The researchers also asked the participants if they have a family member or close friend with their assigned disease, and were surprised to discover personal experience with the disease did not make a difference. According to the research, people responded to the hypothetical risk of disease by wanting to take action regardless of whether or not they have seen the disease up close.
“It is extremely important for social scientists and clinicians to understand how people respond to these risk numbers and how they are being used to make important life decisions,” Dr Almeling said. She added, “Studies like this can aid healthcare providers in offering genetic information with sufficient context to insure that people make the best decisions for themselves.”
According to the researchers, the across-the-board desire to take action in response to hypothetical risk information suggests that everyone is a “patient-in-waiting.”
Joanne Mizell: Lifestyle Modification Programs Take Holistic Aim at Metabolic Disease
May 1st 2024Joanne Mizell shares insurer strategies in addressing the escalating rates of metabolic diseases, highlighting the importance of holistic treatment methods like lifestyle modification programs, which integrate nutrition, physical activity, and community engagement.
Read More
Tackling Health Inequality: The Power of Education and Experience
April 30th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our final episode of this limited series and our conversation with Janine Jelks-Seale, MSPPM, director of health equity at UPMC Health Plan.
Listen
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
The Federal Trade Commission (FTC) issued letters to 10 companies to warn them that certain drug patents were improperly listed; the US Department of Agriculture (USDA) will begin testing ground beef for bird flu particles; rural Americans are more likely to die early from 1 of the 5 leading causes of death than those who live in urban areas.
Read More